HYDRA CE | New Models for TAVR Development

The Hydra CE has shown favorable one year efficacy for the new transcatheter aortic valve model, with large effective orifice and low transvalvular gradient associated to an acceptable complications rate.  With this study, the Hydra will obtain the CE mark and go after FDA approval (just as all new devices). 

HYDRA CE | Surgen nuevos modelos con los que avanza el TAVI

This study looked at safety and performance of the new Hydra valve to treat severe aortic stenosis in high or extreme surgical risk patients. 

Hydra presents a repositionable self-expanding system with supra-annular bovine pericardial leaflets. This emulates the big majority of self-expanding models currently available, as well as those to come.  

The study included 157 patients (79.2 ± 7.1 mean age and 4.7 ± 3.4% STS) with 94.3% successful implantation.

At 30 días, mortality was 7%, including 5.7% cardiovascular deaths; 3.2% were device related.

There was significant improvement of effective orifice area (from 0.7 ± 0.2 cm2 to 1.9 ± 0.6 cm2) and mean aortic valve gradient (from 49.5 ± 18.5 mm Hg to 8.1 ± 3.7 mm Hg). These figures were maintained for a year. 


Read also: Is the Booster Dose Against COVID-19 Effective for All Ages?


Moderate to severe paravalvular leak was observed in 6.3% of patients at 30 days and in 6.9% 1 year. This differs from the observed trend of the rest of self-expanding valves, which tend to show leak improvement at one year. 

Pacemaker implantation rate was 11.7% at 30 days and 12.4% at one year.

Conclusion

This study aiming at obtaining the CE mark, has shown favorable efficacy for the new Hydra, with excellent hemodynamic results and acceptable complications rate. 

Original Title: 30-Day and 1-Year Outcomes With HYDRA Self-Expanding Transcatheter Aortic Valve: The Hydra CE Study.

Reference: Audrius Aidietis et al. JACC Cardiovasc Interv. 2022 Jan 10;15(1):93-104. doi: 10.1016/j.jcin.2021.09.004.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...